摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-fluoro-[1,1'-biphenyl]-3-ol | 10540-41-7

中文名称
——
中文别名
——
英文名称
4'-fluoro-[1,1'-biphenyl]-3-ol
英文别名
4'-fluorobiphenyl-3-ol;3-(4-Fluorophenyl)phenol
4'-fluoro-[1,1'-biphenyl]-3-ol化学式
CAS
10540-41-7
化学式
C12H9FO
mdl
——
分子量
188.201
InChiKey
JCZGBYKFVYILAO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2907199090

SDS

SDS:209ad4c2b1b4614aac4e12ea979ac5a5
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-(4-Fluorophenyl)phenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-(4-Fluorophenyl)phenol
CAS number: 10540-41-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H9FO
Molecular weight: 188.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4'-fluoro-[1,1'-biphenyl]-3-olsodium hydroxide 、 sodium tetrahydroborate 、 PPA 、 对甲苯磺酸 作用下, 以 xylene 为溶剂, 反应 35.0h, 生成 8-(4-fluorophenyl)-N-octan-2-yl-2,3,4,5-tetrahydro-1-benzoxepin-5-amine
    参考文献:
    名称:
    Synthesis and structure-activity relationships of new ACAT inhibitors
    摘要:
    A series of heterocyclic ureas were synthesized and their ability to inhibit arterial and intestinal ACAT was assessed in animals. The structural modifications carried out in this series led to N-2-(2,4-difluorophenyl)-N-1-8-(4-fluorophenyl)-2,3,4,5-tetrahydro-1-benzoxepin-5-yl-N-1-n-heptylurea 21, which proved to be very active on both the inhibition of aortic ACAT and the inhibition of rat cholesterol intestinal absorption, thus exhibiting a strong hypocholesterolemic effect po in the rat (ED(25) = 0.2 mg/kg).
    DOI:
    10.1016/0223-5234(96)88247-x
  • 作为产物:
    描述:
    3-(4-fluorophenyl)cyclohexanone2-二甲氨基吡啶 、 palladium(II) trifluoroacetate 、 氧气对甲苯磺酸 作用下, 以 二甲基亚砜 为溶剂, 80.0 ℃ 、101.33 kPa 条件下, 反应 24.0h, 以65%的产率得到4'-fluoro-[1,1'-biphenyl]-3-ol
    参考文献:
    名称:
    钯催化的取代环己酮有氧脱氢制酚
    摘要:
    苯酚衍生物由可带有多种取代基的非芳香环化合物制备。芳香分子是许多药物、电子材料和日用塑料的关键成分。这些分子的效用直接反映了芳环上取代基的身份和模式。在这里,我们报告了一种钯 (II) 催化剂体系,结合了非常规的邻二甲氨基吡啶配体,用于将取代的环己酮转化为相应的酚类。该反应通过六元环的两个饱和碳-碳键的连续脱氢进行,并使用分子氧作为氢受体。
    DOI:
    10.1126/science.1204183
点击查看最新优质反应信息

文献信息

  • Lewis acid-promoted site-selective cyanation of phenols
    作者:Wu Zhang、Wen Yang、Wanxiang Zhao
    DOI:10.1039/d0ob00737d
    日期:——
    An efficient Lewis acid-promoted site-selective electrophilic cyanation of 3-substituted and 3,4-disubstituted phenols has been developed. The cyanation reactions using MeSCN as the cyanating reagent proceeded efficiently to afford a wide range of 2-hydroxybenzonitriles with high efficiency and excellent regioselectivity. This protocol could provide a practical method for the synthesis and modification
    已经开发出有效的路易斯酸促进的3-取代的和3,4-二取代的苯酚的位点选择性亲电子氰化。使用MeSCN作为氰化试剂的氰化反应可以高效地进行,从而以高效率和出色的区域选择性提供了广泛的2-羟基苄腈。该协议可以为合成和修饰生物活性分子提供实用的方法。
  • Continuous-Flow Synthesis of <i>meta</i>-Substituted Phenol Derivatives
    作者:Jeong Hyeon Park、Chan Yi Park、Mi Jin Kim、Min Uk Kim、Young Joon Kim、Geon-Hee Kim、Chan Pil Park
    DOI:10.1021/acs.oprd.5b00077
    日期:2015.7.17
    complementary microreactor technologies were developed for the study of biphasic gas–liquid reactions and preparation of meta-substituted phenol derivatives. The first capillary microreactor, composed of a T-junction and simple capillary, enabled oxidative Heck/dehydrogenation on a microgram scale with a shortened reaction time; the total sequence time for oxidative Heck/dehydrogenation reactions was optimized
    开发了两种互补的微反应器技术,用于研究气液两相反应和间位反应的制备取代的苯酚衍生物。第一个毛细管微反应器由T型接头和简单的毛细管组成,可实现微克级的氧化Heck /脱氢反应,并缩短了反应时间。氧化性Heck /脱氢反应的总顺序时间从传统的批处理系统中的2160分钟优化到微化学系统中的130分钟。第二个管内微反应器由可透气的内管和不可透气的外管组成,在由第一个微克规模的研究确定的最佳安全性和经济性条件下,成功地进行了克级合成。这两种微反应器在探索涉及气态和液态试剂的反应方面具有巨大潜力。
  • Aerobic Oxidative Heck/Dehydrogenation Reactions of Cyclohexenones: Efficient Access to<i>meta</i>-Substituted Phenols
    作者:Yusuke Izawa、Changwu Zheng、Shannon S. Stahl
    DOI:10.1002/anie.201209457
    日期:2013.3.25
    catalyst, employing a 6,6′‐dimethyl‐2,2′‐bipyridine ligand, promotes both the aerobic oxidative Heck coupling and dehydrogenation reactions of cyclohexenones. These reactions may be combined in a one‐pot sequence to enable the straightforward synthesis of meta‐substituted phenols (see scheme).
    争夺(间)位:一种新型双阳离子钯(II)催化剂,采用 6,6'-二甲基-2,2'-联吡啶配体,促进环己烯酮的有氧氧化 Heck 偶联和脱氢反应。这些反应可以以一锅法顺序组合,以实现间位取代酚的直接合成(参见方案)。
  • 7-AZA-SPIRO[3.5]NONANE-7-CARBOXYLATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    申请人:Abouabdellah Ahmed
    公开号:US20120129830A1
    公开(公告)日:2012-05-24
    The invention relates to compounds of the general formula (I) where: R 2 is a hydrogen or fluorine atom or a hydroxyl, cyano, trifluoromethyl, C 1-6 -alkyl, C 1-6 -alkoxy, or NR 8 R 9 group; m, n, o and p independently are a number from 0 to 3, provided that m+n≦7 and that o+p≦7; A is a covalent bond, an oxygen atom, a C 1-6 -alkylene group or a —O—C 1-6 -alkylene group in which the end that is an oxygen atom is bonded to the R 1 group and the end that is an alkylene group is bonded to the carbon of the bicyclic compound; R 1 is an optionally substituted aryl or heteroaryl group; R 3 is a hydrogen or fluorine atom or a C 1-6 -alkyl or trifluoromethyl group; R 4 is an optionally substituted 5-membered heterocyclic compounds; wherein the compounds can be in the state of a base or an acid addition salt. The invention can be used in therapeutics.
    该发明涉及一般式(I)的化合物,其中:R2为氢或氟原子,或羟基、氰基、三氟甲基、C1-6-烷基、C1-6-烷氧基或NR8R9基团;m、n、o和p独立地为0到3之间的数字,但要求m+n≦7且o+p≦7;A为共价键、氧原子、C1-6-烷基烯基团或—O—C1-6-烷基烯基团,其中以氧原子为端点的部分与R1基团结合,以烷基烯基团为端点的部分与双环化合物的碳结合;R1为可选择取代的芳基或杂环芳基;R3为氢或氟原子,或C1-6-烷基或三氟甲基基团;R4为可选择取代的5-成员杂环化合物;其中这些化合物可以处于碱性或酸性盐的状态。该发明可用于治疗学。
  • [EN] DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS<br/>[FR] DÉRIVÉS DE TRIAZOLOPYRIDAZINES 6-SUBSTITUÉES EN TANT QU'AGONISTES DE REV-ERB
    申请人:GENFIT
    公开号:WO2013045519A1
    公开(公告)日:2013-04-04
    The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.
    本发明提供了新颖的激动Rev-Erb的6-取代[1,2,4]三唑并[4,3-b]吡啶嗪化合物。这些化合物以及包含它们的药物组合物是治疗任何激活Rev-Erb具有治疗效果的疾病的合适手段,例如在炎症和昼夜节律相关疾病或心脏代谢疾病中。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐